Product Images Avapro

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Avapro NDC 0024-5850 by Sanofi-aventis U.s. Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - avapro 01

Chemical Structure - avapro 01

Figure 1 - avapro 02

Figure 1 - avapro 02

Figure 2 - avapro 03

Figure 2 - avapro 03

Figure 3 - avapro 04

Figure 3 - avapro 04

This is a graphical representation of the cumulative event rate (%) in a clinical trial comparing the effects of AVAPRO and Amlodipine with Placebo as a control group over a period of 54-60 months of follow-up. The data shows that AVAPRO has a significant impact on reducing the event rate compared to both Amlodipine and Placebo. There are no further details available apart from the chart.*

PRINCIPAL DISPLAY PANEL - 75 mg Tablet Bottle Label - avapro 05

PRINCIPAL DISPLAY PANEL - 75 mg Tablet Bottle Label - avapro 05

PRINCIPAL DISPLAY PANEL - 150 mg Tablet Bottle Label - avapro 06

PRINCIPAL DISPLAY PANEL - 150 mg Tablet Bottle Label - avapro 06

PRINCIPAL DISPLAY PANEL - 300 mg Tablet Bottle Label - avapro 07

PRINCIPAL DISPLAY PANEL - 300 mg Tablet Bottle Label - avapro 07

Avapro Tablets, with NDC 0024-5852-30, contains 300mg of irbesartan per tablet. The medication is available in a bottle of 30 tablets and is prescribed only. The recommended dosing information can be found in the package insert. It is recommended to store these tablets at a controlled room temperature between 15°C and 30°C (59°F-86°F).*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.